yophilised Oral Faecal Microbiota Transplantation in the Management of Ulcerative Colitis -(LOTUS Study)

Phase 2

• Conditions: lcerative Colitis; Ulcerative Colitis; Oral and Gastrointestinal - Inflammatory bowel disease

• Registration Number: ACTRN12619000611123
• Lead Sponsor: The University of Sydney

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Results First Posted: 1900-01-01
• Study Start: 2019-04-24
• Study Completion: 2021-05-01
• Last Update Posted: 27 June 2022

Recruitment & Eligibility

• Status: Stopped early
• Sex: All
• Target Recruitment: 37

Inclusion Criteria

Confirmed diagnosis of ulcerative colitis of at least 3 months by standard clinical, endoscopic, and histological criteria
-Clinically and endoscopically active ulcerative colitis

Exclusion Criteria

-Acute Severe Colitis
-Crohn's disease
-Proctitis
-Pregnancy or breast feeding
-Previous FMT treatment
-Significant medical comorbidities

Study & Design

• Study Type: Interventional
• Study Design: Not specified